Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8613949 | NOVARTIS | Galenical formulations of organic compounds |
Dec, 2029
(6 years from now) |
Market Authorisation Date: 26 August, 2010
Treatment: NA
Dosage: TABLET;ORAL
4
United States
2
Russia
2
Japan
1
Colombia
1
Ecuador
1
Australia
1
Korea, Republic of
1
Canada
1
Tunisia
1
Peru
1
Malaysia
1
Chile
1
Jordan
1
Morocco
1
Mexico
1
Argentina
1
Brazil
1
China
1
South Africa
1
Taiwan
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic